🇺🇸 FDA
Patent

US 9226919

Methods for dosing an orally active 1,2,4-oxadiazole

granted A61KA61K31/4245A61K47/02

Quick answer

US patent 9226919 (Methods for dosing an orally active 1,2,4-oxadiazole) held by PTC THERAPEUTICS, INC. expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4245, A61K47/02, A61K47/10, A61K47/12